(Image source: Teva Pharmaceutical) In a cost-cutting initiative, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will let go 5,000 employees, which will result in savings of $2 billion a year. The savings will be reinvested in generic drugs and specialty products already in the pipeline. This is a two year restructuring plan. Shares are up above 2 percent on the news.